BMB Reports 2024; 57(2): 122-122  
Erratum to: circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis
Kaiyun Qin1,3,#, Fenghua Zhang2,#, Hongxia Wang1 , Na Wang1 , Hongbing Qiu4 , Xinzhuan Jia1,5, Shan Gong1 & Zhengmao Zhang1,*
1Department of Gynecology, Fourth Hospital of Hebei Medical University, Hebei Shijiazhuang 050011, 2Department of Breast & Thyroid Surgery, Hebei General Hospital, Hebei Shijiazhuang 050057, 3Department of Gynecology, Hebei General Hospital, Hebei Shijiazhuang 050057, 4Department of Gynecology, Hebei Xingtai People’s Hospital, Hebei Shijiazhuang 054001, 5Department of Reproductive Medicine, Fourth Hospital of Hebei Medical University, Hebei Shijiazhuang 050011, China
Received: December 4, 2023; Published online: February 14, 2024.
© Korean Society for Biochemistry and Molecular Biology. All rights reserved.

cc This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Erratum to: BMB Reports 2023; 56(3): 184-189, PMID: 36617466, PMCID: PMC10068343
https://doi.org/10.5483/BMBRep.2022-0175
Body

The BMB Reports would like to correct in BMB Rep. 56(3): 184-189, titled “circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis”.

The original version of this article unfortunately contained image error in the Fig. 3. This article has been updated to correct an error in the image in Fig. 3D.

The author apologizes for any inconvenience or confusion this error may cause. Author information has been modified in the original PDF version.



This Article

e-submission

Archives